T0	Limitation 33493 33502	Inability
T1	Limitation 34801 34809	Although
T2	Limitation 35205 35208	The
T3	Limitation 35448 35451	The
T4	Limitation 35801 35809	Finally,
T5	NonstandardTreatmentCharacteristics 33493 33571	Inability to tolerate 2,000 mg/day despite efforts made to reach the full dose
T6	Limitation 33626 33628	To
T7	NonstandardTreatmentCharacteristics 33642 33682	the variability in the dose administered
T8	SampleSize 35005 35035	only 100 children were studied
T9	UnderpoweredStudy 35063 35203	insufficient power to detect differences between placebo- and metformin-treated groups for some obesity-related comorbid conditions examined
T10	FollowUpDuration 35320 35390	the study did not explore the efficacy of metformin in the longer term
T11	VerySpecificPopulation 35519 35579	only severely obese insulin-resistant children were enrolled
T12	Intervention 35930 35984	it consisted solely of monthly visits with a dietitian
T13	Intervention 35990 36155	the magnitude of metformin-associated weight reduction that might occur among children treated with an intensified behavioral modification regimen is not established
